test

Adam Koppel

@Bain Capital Life Sciences Investors, Llc

Latest period2024 - Q3ReportedManaged Assets$961.176MTotal holdings24
Assets growth rate5.53%Assets growth rate (2-Q avg)-10.63%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bain Capital Life Sciences Investors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 24 positions.

Assets under management

The assets under management (AUM) of Bain Capital Life Sciences Investors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 961.176M in assets, with a quarterly growth rate of 5.53% and a 2-quarter average growth rate of -10.63%. The portfolio is managed by Adam Koppel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
NUVLNuvalent Inc
Recent Activity
28.71%
$275.93M
2.697M shares@ $102.3 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
18.09%
$173.867M
10.474M shares@ $16.61 avg price
IRONDisc Medicine Inc
Recent Activity
9.19%
$88.242M
1.796M shares@ $49.15 avg price
DNTHDianthus Therapeutics Inc
Recent Activity
8.59%
$82.508M
3.013M shares@ $27.39 avg price
SVRASavara Inc
Recent Activity
6.43%
$61.758M
14.565M shares@ $4.25 avg price
PHVSPharvaris N V
Recent Activity
6.37%
$61.179M
3.303M shares@ $18.52 avg price
ANNXAnnexon Inc
Recent Activity
Increased 0.01%
5.21%
$50.023M
8.45M shares@ $5.92 avg price
SLDBSolid Biosciences Inc
Recent Activity
2.93%
$28.121M
4.035M shares@ $6.98 avg price
TNGXTango Therapeutics Inc
Recent Activity
Decreased -6.24%
2.18%
$20.882M
2.712M shares@ $7.71 avg price
KYTXKyverna Therapeutics Inc
Recent Activity
1.72%
$16.471M
3.368M shares@ $4.89 avg price